Epidemiology and Sociocultural Differences for Bladder Cancer
- 464 Downloads
Bladder cancer (BCa) is the second most common genitourinary cancer in men and the most common in women. Every year, worldwide, more than 400,000 patients receive a BCa diagnosis and 145,000 succumb to it. The epidemiology is influenced by several factors such as age, gender, race, geography, sociocultural status, and exposure to risk factors. Women have a lower risk of developing BCa compared to their male counterpart but present with more aggressive features and suffer from worse outcomes. Black patients seem to have a higher risk of advanced disease and worse survival. BCa is typically a disease of the elderly with a higher preponderance in developed countries. However, the change in the geography of smoking from developed to developing countries together with the improvement of life expectancy will lead to an increase in the incidence in these regions. Moreover, in Western countries, mainly due population aging, BCa will become even more frequent, resulting in an even bigger public health challenge. Indeed, BCa is the most cost-intensive cancer per person mainly because of the excessive costs related to the high recurrence rate and ongoing invasive monitoring required in the surveillance of non-muscle invasive BCa (NMIBC) patients. The new revolution in awareness and innovation in BCa will certainly change this disease in the near future.
- Ark JT, Alvarez JR, Koyama T, Bassett JC, Blot WJ, Mumma MT, et al. Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race and risk factors for bladder Cancer. J Urol. 2017;198:1033–8. https://doi.org/10.1016/j.juro.2017.06.083.CrossRefPubMedPubMedCentralGoogle Scholar
- Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, et al. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int. 2016;117:272–9. https://doi.org/10.1111/bju.12984.CrossRefPubMedGoogle Scholar
- GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase No. 11. International Agency for Research on Cancer Web siteGoogle Scholar
- Kluth LA, Rieken M, Xylinas E, Kent M, Rink M, Rouprêt M, et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol. 2014;66:913–9. https://doi.org/10.1016/j.eururo.2013.11.040.CrossRefPubMedGoogle Scholar
- Lyratzopoulos G, Abel GA, Brown CH, Rous BA, Vernon SA, Roland M, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol. 2013;24:843–50. https://doi.org/10.1093/annonc/mds526.CrossRefPubMedGoogle Scholar
- Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y, Kassouf W, et al. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology. 2014;83:863–7. https://doi.org/10.1016/j.urology.2013.10.060.CrossRefPubMedGoogle Scholar
- Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M. SEER cancer statistics review, 1975–2005. Bethesda: National Cancer Institute; 2008.Google Scholar
- Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol. 2006;175:2048–53; discussion 2053. https://doi.org/10.1016/S0022-5347(06)00317-X.CrossRefPubMedGoogle Scholar
- Soria F, Marra G, Čapoun O, Soukup V, Gontero P. Prevention of bladder cancer incidence and recurrence. Curr Opin Urol. 2017:1. https://doi.org/10.1097/MOU.0000000000000453.
- Williams SB, Huo J, Kosarek CD, Chamie K, Rogers SO, Williams MA, et al. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. Cancer Causes Control. 2017;28:755–66. https://doi.org/10.1007/s10552-017-0902-2.CrossRefPubMedPubMedCentralGoogle Scholar